市場調査レポート
商品コード
1308150
医療機器アウトソーシング市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Medical Device Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
医療機器アウトソーシング市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年07月05日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
|
世界の医療機器アウトソーシング市場規模は、2022年に1,157億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて9%の成長率(CAGR)を示し、2028年には1,996億米ドルに達すると予測しています。質の高い手頃な価格のヘルスケアサービスに対する需要の高まり、医療疾患の蔓延の増加、業界における継続的な技術の進歩が、市場を牽引する主な要因のいくつかです。
医療機器アウトソーシングでは、医療機器の製造業務全体を契約ベースで第三者ベンダーに委託します。これにより、企業は経費を削減し、サプライチェーンを合理化し、業界標準や要件を遵守しながら市販製品を市場に投入することができます。また、業務効率と製品品質の向上、ビジネスリスクの最小化、製品開発サイクルと開発の迅速化、先端技術へのアクセスも可能になります。医療機器アウトソーシングには、機器の組み立てやパッケージングのほか、パッケージテストや滅菌バリデーション、定期的な処理、プロセス改善の特定など、さまざまなサービスが含まれます。これに加えて、多くの業界プレーヤーは、医療機器の汚染のない生産を保証するために、オンサイトの医療ラボやクリーンルームなどの専門施設を提供しています。
医療疾患の増加により、質の高いヘルスケアサービスへのニーズが高まっており、これが市場成長を促進する主な要因となっています。さらに、イノベーションと絶え間ない研究開発(R&D)投資を通じて製品ポートフォリオを拡大する必要性が高まっていることも、これを後押ししています。このほか、医療機器の製造・開発のアウトソーシングに伴う費用対効果の高さも、市場に好材料となっています。さらに、医療機器に対する規制要件が増加していることから、市場の大手企業は、製品の安全性に関する厳しい政府規制を遵守しながら、製品のタイムリーな承認を確保するために、規制コンプライアンス・アウトソーシング企業と協力するようになっています。その結果、同市場には収益性の高い成長機会がもたらされています。これに伴い、規制コンプライアンスのアウトソーシングにより、メーカーは自社のコアコンピタンスに集中し、新興市場のニーズに対応しながら生産コストを維持することが可能となり、市場の成長にプラスとなっています。これに加えて、ヘルスケア分野の成長強化、高齢者人口の増加、医療機器の継続的な技術進歩、消費者意識の高まり、患者の安全性とケアの質への注目の高まりが、市場拡大の後押しとなっています。さらに、個別化医療に対する需要の高まり、ウェアラブル医療機器の採用拡大、低侵襲外科手術の人気の移り変わり、在宅医療、遠隔医療、医療ツーリズムの新たな動向が市場拡大に寄与しています。
The global medical device outsourcing market size reached US$ 115.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 199.6 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028. The rising demand for quality and affordable healthcare services, the increasing prevalence of medical ailments, and ongoing technological advancements in the industry represent some of the key factors driving the market.
Medical device outsourcing involves subletting the entire production task of medical devices to a third-party vendor on a contract basis. This, in turn, helps organizations reduce expenses, streamline the supply chain, and bring commercial products to market while adhering to industry standards and requirements. It also improves operational efficiency and product quality, minimizes business risks, accelerates products' development cycles and market entry, and provides access to advanced technologies. Medical device outsourcing includes a range of services such as device assembly and packaging, as well as package testing and sterilization validation, recurring processing, and process improvement identification. In addition to this, many industry players offer specialized facilities, including on-site medical labs and cleanrooms, to ensure the contamination-free production of medical devices.
The increasing prevalence of medical ailments has facilitated the need for quality healthcare services, which represents the prime factor driving the market growth. This is further supported by the rising need to expand product portfolios through innovations and constant research and development (R&D) investments. Besides this, the cost-effectiveness associated with outsourcing medical device manufacturing and development is creating a favorable outlook for the market. Moreover, the increasing regulatory requirement for medical devices is prompting leading market players to collaborate with regulatory compliance outsourcing companies to ensure timely approval of their products while adhering to stringent government regulations on product safety. This, in turn, is presenting remunerative growth opportunities for the market. In line with this, outsourcing regulatory compliance allows manufacturers to focus on their core competencies and maintain production costs while addressing the needs of the emerging market, which is favoring the market growth. In addition to this, the bolstering growth of the healthcare sector, the rising geriatric population, and ongoing technological advancements in medical devices, combined with the escalating consumer awareness and the increasing focus on patient safety and quality of care, are aiding in market expansion. Furthermore, the surging demand for personalized medicine, the expanding adoption of wearable medical devices, the shifting popularity of minimally invasive surgical procedures, and the emerging trend of home healthcare, telemedicine, and medical tourism are contributing to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical device outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, therapeutics and application.
Regulatory Consulting
Product Design and Development
Product Testing and Sterilization
Product Implementation
Product Upgrade
Product Maintenance
The report has provided a detailed breakup and analysis of the medical device outsourcing market based on the service. This includes regulatory consulting, product design and development, product testing and sterilization, product implementation, product upgrade, and product maintenance. According to the report, product design and development represented the largest segment.
Cardiology
Diagnostic Imaging
Orthopedic
IVD
Ophthalmic
General and Plastic Surgery
Drug Delivery
Dental
Endoscopy
Diabetes Care
A detailed breakup and analysis of the medical device outsourcing market based on therapeutics have also been provided in the report. This includes cardiology, diagnostic imaging, orthopedic, IVD, ophthalmic, general and plastic surgery, drug delivery, dental, endoscopy, and diabetes care. According to the report, cardiology accounted for the largest market share.
Class I
Class II
Class III
The report has provided a detailed breakup and analysis of the medical device outsourcing market based on the application. This includes class I, II, and III. According to the report, class II represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for medical device outsourcing. Some of the factors driving the Asia Pacific medical device outsourcing market included the rising prevalence of chronic diseases, the expanding geriatric population, and continuous technological advancements in medical devices.
The report has also provided a comprehensive analysis of the competitive landscape in the global medical device outsourcing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Celestica Inc. (Onex Corporation), Charles River Laboratories International Inc., Flex Ltd., Freyr Inc., Heraeus Holding GmbH, ICON plc, Integer Holdings Corporation, IQVIA Inc., Plexus Corp., Sanmina Corporation, TE Connectivity, and West Pharmaceutical Services Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.